Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Shares Issued (2024 - 2025)

Metagenomi (MGX) has disclosed Shares Issued for 2 consecutive years, with $109000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Shares Issued rose 122.15% to $109000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $109000.0, a N/A change, with the full-year FY2024 number at $84.0 million, changed N/A from a year prior.
  • Shares Issued was $109000.0 for Q3 2025 at Metagenomi, up from -$492000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $86.5 million in Q1 2024 to a low of -$2.0 million in Q2 2024.